Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.2%

1 terminated/withdrawn out of 31 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 2
8(42.1%)
N/A
7(36.8%)
Phase 3
2(10.5%)
Phase 1
2(10.5%)
19Total
Phase 2(8)
N/A(7)
Phase 3(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials
NCT07432932Recruiting

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Role: collaborator

NCT04359732Not ApplicableActive Not Recruiting

Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI

Role: collaborator

NCT05124288Recruiting

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Role: collaborator

NCT05974475Recruiting

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

Role: collaborator

NCT03902665Phase 2Completed

Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

Role: collaborator

NCT02837809Not ApplicableCompleted

Early Lung Cancer Detection in High Risk Individuals

Role: collaborator

NCT06108310Unknown

ArTificial inTelligence-based RAdiogenomics in Colon Tumors

Role: collaborator

NCT03358017Phase 2Completed

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

Role: collaborator

NCT06068023Recruiting

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

Role: collaborator

NCT01357772Phase 3Active Not Recruiting

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

Role: collaborator

NCT02672449Not ApplicableUnknown

Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer

Role: collaborator

NCT05725720Recruiting

Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy

Role: collaborator

NCT05382741Phase 2Unknown

Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial

Role: collaborator

NCT02803086Active Not Recruiting

Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer

Role: collaborator

NCT04781062Not ApplicableUnknown

Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer

Role: collaborator

NCT01248806Completed

Continuous Observation of Smoking Subject

Role: collaborator

NCT05299437Phase 2Unknown

Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry

Role: collaborator

NCT04811898Phase 1Completed

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Role: collaborator

NCT01387503Not ApplicableCompleted

Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging

Role: collaborator

NCT05019989Not ApplicableCompleted

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study

Role: collaborator